title: Asymptomatic carotid artery disease: A personalized approach to management.
abstract: Asymptomatic carotid artery disease is relatively common and poses a challenge for internists as well as vascular specialists when deciding whether to pursue surgical endarterectomy, percutaneous stenting, or medical therapy alone. The authors review the management of asymptomatic carotid disease, reflecting the most current data.
authors.affiliation: Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: Aldo L
authors.initials: AL
authors.lastname: Schenone
authors.affiliation: Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: Aaron
authors.initials: A
authors.lastname: Cohen
authors.affiliation: Director, Endovascular Services, Interventional Cardiology and Vascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA. E-mail: shishem@ccf.org.
authors.forename: Mehdi H
authors.initials: MH
authors.lastname: Shishehbor
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D058070:Asymptomatic Diseases / Q000628:therapy*; D001314:Auscultation; D002340:Carotid Artery Diseases / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D016893:Carotid Stenosis / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D003920:Diabetes Mellitus / Q000188:drug therapy; D019468:Disease Management; D016894:Endarterectomy, Carotid; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008403:Mass Screening; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D016540:Smoking Cessation; D015607:Stents; D020521:Stroke / Q000517:prevention & control*
chemical_list: D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents; D010975:Platelet Aggregation Inhibitors